CureDuchenne Commits $1 Million to Gennao Bio to Accelerate Duchenne Muscular Dystrophy and Rare Muscle Disease Research

NEWPORT BEACH, Calif.: NEWPORT BEACH, Calif., Dec. 22, 2021 /PRNewswire/ -- CureDuchenne Ventures, a subsidiary of CureDuchenne, a leading global nonprofit focused on finding and funding a cure for Duchenne muscular dystrophy, announces a $1 million investment in Gennao Bio. CureDuchenne's commitment is a part of Gennao Bio's Series A...

Click to view original post